Moreover, resistance to 5-fluorouracil (5-FU) in colorectal cancer has been linked to the overexpression of thymidylate synthase (TYMS) and increased dUTPase activity, which together drive competitive inhibition of the drug’s molecular target (100, 101). The gene discussed is TYMS; the disease is colorectal cancer.